Clinical Trials Directory

Trials / Completed

CompletedNCT00989040

Impact of Neuropathic Post-Zosterian Pain on the Cognition

Impact of Neuropathic Post-zosterian Pain on the Cognition (NPZ and Cognition)

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
University Hospital, Clermont-Ferrand · Academic / Other
Sex
All
Age
55 Years
Healthy volunteers
Accepted

Summary

Pain is defined as a sensorial and emotional phenomenon and lead consequences on the cognition. These consequences could be increased with usual treatment. So the aim of this study is to explore these cognitive consequences.

Detailed description

Pilot prospective study with parallel groups

Conditions

Interventions

TypeNameDescription
DRUGusual treatment: Versatis* To explore if the cognition is failed in treated patients suffering of neuropathic postzosteria pain. * To see if treated patients with patch (Versatis®) have better cognition than treated patients without patch.

Timeline

Start date
2009-03-01
Primary completion
2009-06-01
Completion
2009-09-01
First posted
2009-10-02
Last updated
2012-01-30

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT00989040. Inclusion in this directory is not an endorsement.

Impact of Neuropathic Post-Zosterian Pain on the Cognition (NCT00989040) · Clinical Trials Directory